Biomerica, Inc.
BMRA
$3.88
$0.123.19%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.68M | 5.58M | 5.51M | 5.41M | 5.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.68M | 5.58M | 5.51M | 5.41M | 5.41M |
| Cost of Revenue | 4.91M | 4.98M | 5.02M | 4.81M | 4.79M |
| Gross Profit | 765.00K | 597.00K | 485.00K | 608.00K | 617.00K |
| SG&A Expenses | 4.83M | 5.32M | 5.67M | 5.48M | 5.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.78M | 11.47M | 12.01M | 11.78M | 12.08M |
| Operating Income | -5.10M | -5.89M | -6.50M | -6.37M | -6.68M |
| Income Before Tax | -4.85M | -5.59M | -6.14M | -5.94M | -6.30M |
| Income Tax Expenses | 4.00K | 12.00K | 23.00K | 42.00K | 48.00K |
| Earnings from Continuing Operations | -4.85 | -5.61 | -6.16 | -5.98 | -6.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.85M | -5.61M | -6.16M | -5.98M | -6.35M |
| EBIT | -5.10M | -5.89M | -6.50M | -6.37M | -6.68M |
| EBITDA | -5.01M | -5.80M | -6.42M | -6.29M | -6.60M |
| EPS Basic | -2.23 | -2.66 | -2.93 | -2.84 | -3.03 |
| Normalized Basic EPS | -1.39 | -1.66 | -1.82 | -1.76 | -1.88 |
| EPS Diluted | -2.32 | -2.75 | -2.99 | -2.91 | -3.06 |
| Normalized Diluted EPS | -1.39 | -1.66 | -1.82 | -1.76 | -1.88 |
| Average Basic Shares Outstanding | 8.74M | 8.45M | 8.41M | 8.41M | 8.38M |
| Average Diluted Shares Outstanding | 8.74M | 8.45M | 8.41M | 8.41M | 8.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |